Matthew T Plavan's most recent trade in Origin Materials Inc was a trade of 40,000 Common Stock done at an average price of $0.2 . Disclosure was reported to the exchange on Dec. 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Origin Materials Inc | Matthew T. Plavan | CFO and COO | Sale of securities on an exchange or to another person at price $ 0.21 per share. | 26 Dec 2025 | 40,000 | 1,320,231 | - | 0.2 | 8,384 | Common Stock |
| Origin Materials Inc | Matthew T. Plavan | CFO and COO | Sale of securities on an exchange or to another person at price $ 0.55 per share. | 03 Nov 2025 | 150,000 | 1,360,231 | - | 0.6 | 82,500 | Common Stock |
| Origin Materials Inc | Matthew T. Plavan | CFO and COO | Sale of securities on an exchange or to another person at price $ 0.86 per share. | 05 Mar 2025 | 9,725 | 1,510,231 | - | 0.9 | 8,343 | Common Stock |
| Origin Materials Inc | Matthew T. Plavan | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 80,368 | 1,519,956 | - | 0 | Common Stock | |
| Origin Materials Inc | Matthew T. Plavan | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2024 | 241,000 | 1,464,088 | - | 0 | Common Stock | |
| Origin Materials Inc | Matthew T. Plavan | CFO and COO | Sale of securities on an exchange or to another person at price $ 1.02 per share. | 23 Dec 2024 | 24,500 | 1,439,588 | - | 1.0 | 25,110 | Common Stock |
| Origin Materials Inc | Matthew T. Plavan | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.32 per share. | 04 Nov 2024 | 120,000 | 1,223,088 | - | 1.3 | 157,860 | Common Stock |
| Origin Materials Inc | T. Matthew Plavan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 241,105 | 1,343,088 | - | 0 | Common Stock | |
| Arcadia Biosciences Inc | Matthew T. Plavan | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2021 | 250,000 | 435,450 | - | - | Stock Option (right to buy) | |
| Arcadia Biosciences Inc | Matthew T. Plavan | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.16 per share. | 21 Jan 2021 | 585 | 14,285 (0%) | 0% | 3.2 | 1,849 | Common Stock |